Agios Pharmaceuticals (AGIO) Accumulated Expenses (2012 - 2026)
Agios Pharmaceuticals' Accumulated Expenses came in at $34.65 million for Q2 2026, down 1.8% from $35.29 million a year earlier but up 31.8% from the prior quarter.
Powered by 
Analysis
Agios Pharmaceuticals (AGIO) Accumulated Expenses (2012 - 2026) Analysis & Trends
At the end of FY2025, Agios Pharmaceuticals' Accumulated Expenses was $45.46 million, down 3.0% from FY2024.
- Accumulated Expenses carries a five-year compound annual growth rate of 8.1% (FY2020 to FY2025).
- Going back by year, Accumulated Expenses was $46.86 million in FY2024 (+8.6%), $43.17 million in FY2023 (+42.2%), $30.35 million in FY2022 (-5.1%) and $31.97 million in FY2021 (+3.8%).
- The five-year range for quarterly Accumulated Expenses is $19.75 million (Q1 2022) to $46.86 million (Q4 2024).
- Year-over-year, Accumulated Expenses increased in four of the last eight quarters, with growth averaging 3.8%.
- The fastest year-over-year change in Accumulated Expenses over five years came in Q4 2023 (growth of 42.2%), and the weakest in Q3 2021 (a decline of 41.2%).
- Business Quant data shows AGIO's Accumulated Expenses at $26.29 million (Q1 2026), $45.46 million (Q4 2025) and $37.22 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Agios Pharmaceuticals | 1.90 Bn | -940.41 Mn | 52.86 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 38.01 Mn |
| Jun 30, 2026 | 34.65 Mn |
| Mar 31, 2026 | 26.29 Mn |
| Dec 31, 2025 | 45.46 Mn |
| Sep 30, 2025 | 37.22 Mn |
| Jun 30, 2025 | 35.29 Mn |
| Mar 31, 2025 | 20.76 Mn |
| Dec 31, 2024 | 46.86 Mn |
| Sep 30, 2024 | 33.31 Mn |
| Jun 30, 2024 | 36.74 Mn |
| Mar 31, 2024 | 25.13 Mn |
| Dec 31, 2023 | 43.17 Mn |
| Sep 30, 2023 | 30.49 Mn |
| Jun 30, 2023 | 29.19 Mn |
| Mar 31, 2023 | 22.46 Mn |
| Dec 31, 2022 | 30.35 Mn |
| Sep 30, 2022 | 29.76 Mn |
| Jun 30, 2022 | 28.38 Mn |
| Mar 31, 2022 | 19.75 Mn |
| Dec 31, 2021 | 31.97 Mn |
API Access
Agios Pharmaceuticals Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=AGIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "AGIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=AGIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();